Literature DB >> 16300455

After the diagnosis: adherence and persistence with hypertension therapy.

.   

Abstract

Poor adherence to therapy is a major reason that large percentage of patients with hypertension fail to achieve good blood pressure control. Side effects, such as cough, dizziness, nausea, and headache, are frequently cited as reasons for lack of adherence and persistence with hypertension therapy. Use of newer classes of antihypertensive agents with better tolerability than older agents may be one way to improve adherence and persistence. Recent studies have shown higher rates of adherence and persistence with therapy in patients treated with angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, or newer calcium channel blockers compared with other antihypertensive agents. Health insurance coverage can also affect patient adherence and persistence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300455

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  8 in total

1.  Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study.

Authors:  L A Donnelly; A S F Doney; R Tavendale; C C Lang; E R Pearson; H M Colhoun; M I McCarthy; A T Hattersley; A D Morris; C N A Palmer
Journal:  Clin Pharmacol Ther       Date:  2010-12-22       Impact factor: 6.875

Review 2.  Economic benefits of treating high-risk hypertension with angiotensin II receptor antagonists (blockers).

Authors:  Antonio Coca
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

3.  Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study.

Authors:  Joerg Hasford; Detlef Schröder-Bernhardi; Marietta Rottenkolber; Karel Kostev; Gerhard Dietlein
Journal:  Eur J Clin Pharmacol       Date:  2007-08-14       Impact factor: 2.953

4.  Initial antihypertensive prescriptions, switching patterns and adherence among insured patients in Hawai'i.

Authors:  Kikikipa Kretzer; Deborah Taira Juarez; James Davis
Journal:  Hawaii Med J       Date:  2008-04

5.  Expedited blood pressure control with initial angiotensin II antagonist/diuretic therapy compared with stepped-care therapy in patients with ambulatory systolic hypertension.

Authors:  Yves Lacourcière; Luc Poirier; Jean Lefebvre
Journal:  Can J Cardiol       Date:  2007-04       Impact factor: 5.223

6.  Topical preparations for pain relief: efficacy and patient adherence.

Authors:  Liliana L Jorge; Caroline C Feres; Vitor Ep Teles
Journal:  J Pain Res       Date:  2010-12-20       Impact factor: 3.133

Review 7.  Rationale for multiple risk intervention: the need to move from theory to practice.

Authors:  Leif R Erhardt
Journal:  Vasc Health Risk Manag       Date:  2007

Review 8.  The treatment of hypertension in people with dementia: a systematic review of observational studies.

Authors:  Tomas J Welsh; John R Gladman; Adam L Gordon
Journal:  BMC Geriatr       Date:  2014-02-12       Impact factor: 3.921

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.